Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/29/2008EP1749011B1 Bicyclic heterocycles as hiv integrase inhibitors
10/29/2008EP1727809B8 Substituted morpholine and thiomorpholine derivatives
10/29/2008EP1727798B1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
10/29/2008EP1696954B1 Vaccine composition admixed with an alkylphosphatidylcholine
10/29/2008EP1668001B1 Substituted heteroaryl benzofuran acids
10/29/2008EP1664016B1 Therapeutic agents useful for treating pain
10/29/2008EP1660504B1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents
10/29/2008EP1660474B1 Substituted thiophenes and uses thereof
10/29/2008EP1653914A4 Oxime substituted imidazo-containing compounds
10/29/2008EP1648889B1 Isethionate salt of a selective cdk4 inhibitor
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1641447B1 Method of purifying pravastatin
10/29/2008EP1606269B1 Biaryl substituted triazoles as sodium channel blockers
10/29/2008EP1596857B1 Pmcol for the treatment of prostate cancer
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008EP1539242A4 A composition and method to augment and sustain neurotransmitter production
10/29/2008EP1537163B1 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008EP1506195B1 Non-nucleoside reverse transcriptase inhibitors
10/29/2008EP1505959B1 Use of edg receptor binding agents in cancer
10/29/2008EP1487285B9 Alertness bar
10/29/2008EP1453494B1 Use of a sphingosine derivative for the treatment of microbial infections
10/29/2008EP1425264B1 C2-disubstituted indane-1-ol systems and their use as medicaments
10/29/2008EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives
10/29/2008EP1406698B1 Lipoxin analogs as novel inhibitors of angiogenesis
10/29/2008EP1317256B1 Pharmaceutical composition having modified carrier
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1278574B1 Topical composition for the treatment of psoriasis and related skin disorders
10/29/2008EP1265608B1 Oxazolidinone tablet formulation
10/29/2008EP1263739B9 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008EP1208217B1 Antibody dependent enhancement (ade) of alphavirus infection
10/29/2008EP1144592B1 Substrate for cell growth
10/29/2008EP1116791B1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
10/29/2008EP1037611B1 Biodegradable mixed polymeric micelles for gene delivery
10/29/2008EP0990440B1 Pharmaceutical composition comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, a lecithin and a saccharide
10/29/2008EP0979292B1 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
10/29/2008EP0898580B3 Methods and means for inhibition of cdk4 activity
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008EP0831912B2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008CN101296929A Tricyclic compounds useful as oxytocin receptor agonists
10/29/2008CN101296928A Compounds and compositions as protein kinase inhibitors
10/29/2008CN101296926A Heterocyclic aspartyl protease inhibitors
10/29/2008CN101296925A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296924A Pyrazole-isoquinoline urea derivatives as P38 kinase inhibitors
10/29/2008CN101296922A Kinase inhibitors
10/29/2008CN101296921A S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
10/29/2008CN101296920A Functionally selective alpha2C adrenoreceptor agonists
10/29/2008CN101296916A Dihydroxyanthraquinones and their use
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296912A Theramutein modulators
10/29/2008CN101296909A Pyrazine derivatives and use as pI3K inhibitors
10/29/2008CN101296908A Tricyclo substituted amides as glucokinase modulators
10/29/2008CN101296907A Diaminopyrimidines as P2X3 and P2X2/3 modulators
10/29/2008CN101296906A (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds
10/29/2008CN101296904A Amide derivatives as kinase inhibitors
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN101296898A Histamine-3 receptor antagonists
10/29/2008CN101296897A PPAR modulating biaromatic compounds
10/29/2008CN101296894A Novel method for preparing quaternary acid and ammonium salts
10/29/2008CN101296892A PPAR active compounds
10/29/2008CN101296731A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296707A Method for prevention and/or treatment of rheumatoid arthritis
10/29/2008CN101296703A Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same
10/29/2008CN101296702A Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
10/29/2008CN101296701A A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
10/29/2008CN101296700A Aerosolformulation for inhalation
10/29/2008CN101296699A Pyrazolo[1,5-a]pyrimidine compounds
10/29/2008CN101296698A A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
10/29/2008CN101296697A Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
10/29/2008CN101296695A Combinations comprising AMXAA for the treatment of cancer
10/29/2008CN101296694A Pharmaceutical gallium compositions and methods
10/29/2008CN101296693A Endurance improver
10/29/2008CN101296691A Transdermal drug delivery formulation
10/29/2008CN101296690A Liquid dosage forms having enteric properties of delayed and then sustained release
10/29/2008CN101296689A Micronised azodicarbonamide, the preparation and use thereof
10/29/2008CN101294173A Method for the manufacture of bengamide derivatives
10/29/2008CN101294158A Small numerator interference RNA for inhibiting vascellum endometrial hyperplasia
10/29/2008CN101293908A Modified oligonucleotides for telomerase inhibition
10/29/2008CN101293905A Benzoxazole ketone glycoside compounds and preparation method thereof
10/29/2008CN101293904A New compound, preparation method and application thereof
10/29/2008CN101293899A Acyclic nucleoside phosphonate derivative and medicine use thereof
10/29/2008CN101293894A 2-propylidene-19-nor-vitamin D compounds
10/29/2008CN101293889A Water-soluble arteannuin derivative and preparation method thereof
10/29/2008CN101293888A Xanthine derivative, production and use thereof as a medicament
10/29/2008CN101293886A Preparing method and application of white banksia rose endogenetic epiphyte product of snail optical black shell bacterium ketone A
10/29/2008CN101293876A Benzoxazole ketones derivative and preparation method thereof
10/29/2008CN101293871A 7-chlorine-4-[4í»-(7íŒ-chloroquine-4íŒ-base)diethylenediamine-1í»-base]quinoline and uses thereof
10/29/2008CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
10/29/2008CN101293836A 1-oxygen-substituted benzene formyl quinic acid pharmaceutical use of inhibiting hepatitis B virus
10/29/2008CN101293834A 3,4-di-oxygen-[3-substituted alkene propionyl]quinic acid compounds and medicine uses thereof
10/29/2008CN101293833A 5-oxygen-substituted benzene alkene propionyl quinic acid compounds and medicine uses thereof
10/29/2008CN101293831A Uses of 3-hydroxy fatty acid and its derivative in preparing calcium ion duct modifying agent
10/29/2008CN101293830A 1-oxygen-[3-aryl substituted-alkene propionyl]quinic acid compounds and uses
10/29/2008CN101293821A Compounds for inhibiting multi-medicine medicine-resistant staphylococcus aureus activity
10/29/2008CN101293102A Non-virogene carrier for complexation platinum series antineoplastic medicament and preparing method thereof
10/29/2008CN101293088A Medicament for treating rectum cancer and stomach cancer
10/29/2008CN101293078A Intelligence benefiting calcium for children
10/29/2008CN101293075A Drynaria pearl calcium
1 ... 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 ... 7860